Suzanne D. Conzen

Suzanne D. Conzen, M.D., M.Sc., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and Chief of the Division of Hematology and Oncology. She specializes in breast cancer diagnosis and treatment, with a focus on glucocorticoid receptor signaling in cancers. Dr. Conzen earned a B.A. in Political Science from Brown University (magna cum laude), an M.D. from Yale School of Medicine, and an M.Sc. from the London School of Hygiene & Tropical Medicine. Her research spans molecular oncology, including roles of glucocorticoid receptor in breast, prostate, and ovarian cancers, funded by National Cancer Institute grants and the Breast Cancer Research Foundation.

Professional roles include editorships at Cancer Research, NIH Study Section leadership, and committee memberships at UT Southwestern. Awards include election to the American Society for Clinical Investigation (2006) and Association of American Physicians (2020). Her lab investigates therapy resistance mechanisms, leveraging imaging (MRI) and molecular profiling to identify new therapeutic targets. Collaborations bridge clinical oncology with basic science, emphasizing translational research.

Key contributions include discovering glucocorticoid receptor’s role in breast cancer biology and its impact on therapy resistance in prostate/ovarian cancers. Her interdisciplinary work integrates imaging technologies (e.g., radiomics, spectroscopy) to predict cancer progression and recurrence risks. Grants and peer-reviewed funding support her lab’s exploration of stress hormones’ effects on mammary development and tumorigenesis.